# Major Recall Alert: Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag Recalled Due to Product Mix-Up with Tranexamic Acid
Amneal Pharmaceuticals LLC recently issued a nationwide recall for a lot of its **Magnesium Sulfate in Water for Injection, USP, 4g/100mL IV bags**. This urgent recall was triggered after an incident where a **Magnesium Sulfate pouch** was found to contain an **IV bag of Tranexamic Acid (TXA) with 0.7% Sodium Chloride Injection, 10 mg/mL**—posing serious health risks for patients.
This recall, officially announced on **March 24, 2026**, has been conducted with the guidance of the **U.S. Food and Drug Administration (FDA)**. Hospitals, distributors, and healthcare providers are urged to take immediate action to prevent potential adverse effects on patients.
## Why This Recall is Important
This recall is critical because of the potential **life-threatening consequences** of the mix-up. Magnesium Sulfate, commonly used in **pregnant individuals** for conditions like **preeclampsia, eclampsia**, and **preterm labor**, helps prevent seizures and supports preterm neonatal care. A delay or disruption in magnesium therapy could lead to:
- **Seizures in pregnant individuals due to preeclampsia or eclampsia**
- **Serious complications for preterm neonates** due to premature delivery
If incorrectly administered, Tranexamic Acid (intended to control bleeding conditions like hemophilia) can cause severe side effects, including:
- **Blood clotting risks**
- **Seizures**
- **Hypersensitivity reactions**
- **Visual disturbances and dizziness**
Fortunately, as of now, **no adverse events have been reported** regarding this recall. However, immediate precautions must still be taken.
---
## Details of the Recall
Here’s everything you need to know about the recall:
- **Product Involved**: Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag
- **National Drug Code (NDC):** 70121-1720-3
- **Affected Lot Number**: Lot AH250162
- **Distribution**: The impacted product was distributed **nationwide to hospitals and distributors** between December 22, 2025, and February 27, 2026.
- **Packaging**: 12 x 100mL pouches per carton
Amneal Pharmaceuticals has conducted a thorough inspection of their remaining stock and found no additional product mix-ups. Each Tranexamic Acid bag is visibly labeled with product details and a scannable barcode, reducing the likelihood of misidentification in hospital settings.
For the official recall notice, visit the [FDA Safety Alerts page](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-magnesium-sulfate-water-injection-usp).
---
## What You Should Do
Amneal Pharmaceuticals advises hospitals and distributors to:
1. **Quarantine any Magnesium Sulfate IV Bags from Lot AH250162 immediately.**
2. **Stop all usage of the identified product** to ensure patient safety.
3. **Return the recalled product** to the following address:
- **Amneal Pharmaceuticals, Magnesium Sulfate Recall Coordinator**
- 21 Colonial Drive, Piscataway, NJ 08854.
Hospitals with questions regarding the recall can contact Amneal Pharmaceuticals via:
- **Phone**: 833-582-0812 (Monday–Friday, 8:00 AM to 5:00 PM EST)
- **Fax**: 631-983-2595
- **Email**: MagnesiumSulfateRecall@amneal.com
**Reporting Adverse Reactions**: If you or your patients experience adverse reactions or quality issues, report them immediately to the **FDA MedWatch Adverse Reporting Program**:
- **Online**: [FDA MedWatch](https://www.fda.gov/medwatch)
- **By Mail or Fax**: Download the reporting form at the FDA MedWatch website.
---
## Stay Safe – Get Instant Recall Alerts
Health and safety should never be compromised. Keep yourself informed with real-time safety updates on recalls like this. Download our **Free Recall Alert App** today to receive instant notifications on product recalls that matter to you. Stay ahead and stay safe with the best tools for protecting your health and well-being.
This recall highlights the importance of **comprehensive safety checks in healthcare settings**. Though no adverse events have been reported, vigilance remains key to safeguarding patient care.
**For more information, visit the official [FDA Recall Announcement here](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-magnesium-sulfate-water-injection-usp).**